SCHEMBL2818258

SCHEMBL2818258

CC(C)c1ccc(NC(=O)Nc2[nH]c(-c3ccc(CC(=O)O)cc3)nc2C(N)=O)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KIF11 P52732 1/20 0.43
POLB P06746 2/20 0.42
KDM4E B2RXH2 1/20 0.42
MEN1 O00255 2/20 0.42
KMT2A Q03164 2/20 0.42
DGAT1 O75907 3/20 0.41
HPSE Q9Y251 3/20 0.40
RORC P51449 1/20 0.40
RAB9A P51151 2/20 0.40
RET P07949 1/20 0.40
PTGDR2 Q9Y5Y4 1/20 0.40
SOAT1 P35610 1/20 0.40
NPC1 O15118 1/20 0.40
ALDH1A1 P00352 1/20 0.40
GAA P10253 1/20 0.40
MAPT P10636 1/20 0.40
NFKB1 P19838 1/20 0.40
NFKB2 Q00653 1/20 0.40
RELA Q04206 1/20 0.40
CA12 O43570 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2812209 0.89 MEN1 (0.44) POLBKDM4EMEN1KMT2ADGAT1
SCHEMBL2815672 0.85 RAB9A (0.45) KIF11MEN1KMT2ARAB9ANPC1
SCHEMBL2816747 0.85 DGAT1 (0.44) POLBKDM4EMEN1KMT2ADGAT1
SCHEMBL2812631 0.84 EPHX2 (0.44) KIF11MEN1KMT2AHPSERORC
SCHEMBL2819129 0.82 MEN1 (0.47) KDM4EMEN1KMT2ARAB9ANPC1
SCHEMBL2817001 0.82 KDM4E (0.46) POLBKDM4EMEN1KMT2ARAB9A
SCHEMBL2814782 0.78 HPSE (0.44) POLBMEN1KMT2ADGAT1HPSE
SCHEMBL2816860 0.77 ADORA2B (0.43) MEN1KMT2ARAB9AMAPT
SCHEMBL3994385 0.76 NR1H4 (0.46) MEN1KMT2ADGAT1RAB9ASOAT1
SCHEMBL2816165 0.76 COPS5 (0.43) KIF11POLBMEN1KMT2ARAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100249132-A1 IMIDAZOLE DERIVATIVES MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 2010-09-30 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100249132-A1 IMIDAZOLE DERIVATIVES SDHA, SDHB, TPD52L2 KIF11 2526/4885POLB 2686/4885KDM4E 506/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.